StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.02 (-11.19%)

Close on Nov 16, 2026Market cap $466.42KP/E –Yield –

Arcadia Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Arcadia Biosciences's operating margin for the twelve months ending Jun 30, 2026 was -80.1%. For fiscal 2025 it was -51.5%, against -72.3% the year before. The highest annual figure on record is -51.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-51.5%+20.8
FY2024Dec 31, 2024-72.3%+64.7
FY2023Dec 31, 2023-137.0%+51.8
FY2022Dec 31, 2022-188.8%+335.2
FY2021Dec 31, 2021-524.0%−364.9
FY2020Dec 31, 2020-159.0%+1498.9
FY2019Dec 31, 2019-1657.9%−505.6
FY2018Dec 31, 2018-1152.3%−796.8
FY2017Dec 31, 2017-355.6%+228.5
FY2016Dec 31, 2016-584.1%−296.6
FY2015Dec 31, 2015-287.5%−70.4
FY2014Dec 31, 2014-217.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-34.4%+0.1
Q1 FY2026Mar 31, 2026-70.8%−115.0
Q4 FY2025Dec 31, 2025-152.6%+34.8
Q3 FY2025Sep 30, 2025-88.5%+26.0
Q2 FY2025Jun 30, 2025-34.4%−186.0
Q1 FY2025Mar 31, 202544.2%+205.1
Q4 FY2024Dec 31, 2024-187.4%−33.9
Q3 FY2024Sep 30, 2024-114.5%−6.9
Q2 FY2024Jun 30, 2024151.6%+263.7
Q1 FY2024Mar 31, 2024-160.9%+153.0
Q4 FY2023Dec 31, 2023-153.5%+472.5
Q3 FY2023Sep 30, 2023-107.6%+146.6
Q2 FY2023Jun 30, 2023-112.1%−14.0
Q1 FY2023Mar 31, 2023-313.9%−170.3
Q4 FY2022Dec 31, 2022-626.1%+9.8
Q3 FY2022Sep 30, 2022-254.2%+112.5
Q2 FY2022Jun 30, 2022-98.1%+448.7
Q1 FY2022Mar 31, 2022-143.6%+499.7
Q4 FY2021Dec 31, 2021-635.8%−740.6
Q3 FY2021Sep 30, 2021-366.7%+2047.6
Q2 FY2021Jun 30, 2021-546.8%+1900.2
Q1 FY2021Mar 31, 2021-643.2%+1230.5
Q4 FY2020Dec 31, 2020104.8%+1063.6
Q3 FY2020Sep 30, 2020-2414.3%−834.5
Q2 FY2020Jun 30, 2020-2447.0%+7.2
Q1 FY2020Mar 31, 2020-1873.8%+795.8
Q4 FY2019Dec 31, 2019-958.9%+21.7
Q3 FY2019Sep 30, 2019-1579.8%−472.0
Q2 FY2019Jun 30, 2019-2454.2%−1404.2
Q1 FY2019Mar 31, 2019-2669.6%−875.7
Q4 FY2018Dec 31, 2018-980.6%−770.5
Q3 FY2018Sep 30, 2018-1107.8%−494.1
Q2 FY2018Jun 30, 2018-1050.0%−672.9
Q1 FY2018Mar 31, 2018-1793.9%−1404.6
Q4 FY2017Dec 31, 2017-210.1%+803.1
Q3 FY2017Sep 30, 2017-613.8%−248.4
Q2 FY2017Jun 30, 2017-377.1%–
Q1 FY2017Mar 31, 2017-389.3%–
Q4 FY2016Dec 31, 2016-1013.1%–
Q3 FY2016Sep 30, 2016-365.3%–

More Arcadia Biosciences figures

See a number that looks wrong?